Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease hepatitis c
Symptom C0079731|b-cell lymphoma
Sentences 6
PubMedID- 22736295 Clinical outcome of diffuse large b-cell lymphoma (dlbcl) patients with hepatitis c virus (hcv) infection in the rituximab era remains unclear.
PubMedID- 25899771 Prognostic impact of hepatitis c virus infection in patients with diffuse large b-cell lymphoma treated with immunochemotherapy in the context of a novel prognostic index.
PubMedID- 23465418 Early-stage splenic diffuse large b-cell lymphoma is highly associated with hepatitis c virus infection.
PubMedID- 25381127 The notch pathway is recurrently mutated in diffuse large b-cell lymphoma associated with hepatitis c virus infection.
PubMedID- 20823454 Hepatic toxicity and prognosis in hepatitis c virus-infected patients with diffuse large b-cell lymphoma treated with rituximab-containing chemotherapy regimens: a japanese multicenter analysis.
PubMedID- 21188204 In a review of eighteen hepatitis c infected patients with indolent b-cell lymphoma, an overall response rate of the lymphoma after antiviral treatment alone was 63% and 80%, respectively, in the group receiving interferon plus ribavirin and pegylated interferon plus ribavirin, respectively .

Page: 1